实现风湿学目标治疗策略的挑战。
Challenges in Implementing Treat-to-Target Strategies in Rheumatology.
机构信息
Division of Rheumatology, Brigham and Women's Hospital, 60 Fenwood Road, Boston, MA 02115, USA.
Division of Rheumatology, Brigham and Women's Hospital, 60 Fenwood Road, Boston, MA 02115, USA; Division of Pharmacoepidemiology, Brigham and Women's Hospital, 60 Fenwood Road, Boston, MA 02115, USA.
出版信息
Rheum Dis Clin North Am. 2019 Feb;45(1):101-112. doi: 10.1016/j.rdc.2018.09.007.
Abstract
Despite evidence that treat-to-target (TTT) approaches lead to better disease outcomes in RA, TTT is not widely implemented in rheumatology clinics in North America. This article discusses the barriers (including access to care, patient and physician factors, and systems issues) to implementing TTT in the clinic, and proposes possible solutions and future research directions.
摘要
尽管有证据表明，达标治疗（Treat-to-Target，TTT）方法可改善类风湿关节炎（rheumatoid arthritis，RA）的疾病结局，但在北美的风湿科诊所中，TTT 并未广泛实施。本文讨论了在临床实践中实施 TTT 的障碍（包括获得医疗服务的机会、患者和医生因素以及系统问题），并提出了可能的解决方案和未来的研究方向。
相似文献
1
Challenges in Implementing Treat-to-Target Strategies in Rheumatology.
Rheum Dis Clin North Am. 2019 Feb;45(1):101-112. doi: 10.1016/j.rdc.2018.09.007.
2
Implementation of Treat-to-Target in Rheumatoid Arthritis Through a Learning Collaborative: Results of a Randomized Controlled Trial.
Arthritis Rheumatol. 2017 Jul;69(7):1374-1380. doi: 10.1002/art.40111. Epub 2017 May 31.
3
Barriers to treatment adjustment within a treat to target strategy in rheumatoid arthritis: a secondary analysis of the TRACTION trial.
Rheumatology (Oxford). 2018 Nov 1;57(11):1933-1937. doi: 10.1093/rheumatology/key179.
4
Rheumatoid arthritis: 2014 treat-to-target RA recommendations--strategy is key.
Nat Rev Rheumatol. 2015 Sep;11(9):509-11. doi: 10.1038/nrrheum.2015.98. Epub 2015 Jul 21.
5
Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM).
Ann Rheum Dis. 2020 Apr;79(4):453-459. doi: 10.1136/annrheumdis-2019-216819. Epub 2020 Feb 24.
6
2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Arthritis Rheumatol. 2017 Aug;69(8):1538-1551. doi: 10.1002/art.40149. Epub 2017 Jun 16.
7
Long-term prognosis and quality of life in patients with early rheumatoid arthritis treated according to the 2015 ACR guideline (LELAND): protocol for a multicentre prospective observational study in Southern China.
BMJ Open. 2018 Nov 15;8(11):e023798. doi: 10.1136/bmjopen-2018-023798.
8
Assessing the need for improved access to rheumatology care: a survey of Massachusetts community health center medical directors.
J Clin Rheumatol. 2013 Oct;19(7):361-6. doi: 10.1097/RHU.0b013e3182a6a490.
9
Treat-to-Target Approach in Rheumatoid Arthritis: A Quality Improvement Trial.
Arthritis Care Res (Hoboken). 2021 Feb;73(2):207-214. doi: 10.1002/acr.24114.
10
Treat-to-target and shared decision making in rheumatoid arthritis treatment: Is it feasible?
Int J Rheum Dis. 2019 Sep;22(9):1706-1713. doi: 10.1111/1756-185X.13664. Epub 2019 Jul 30.
引用本文的文献
1
Advancing treat-to-target in SLE: a pilot study using a clinical decision support system.
Lupus Sci Med. 2025 Aug 22;12(2):e001605. doi: 10.1136/lupus-2025-001605.
2
Barriers and facilitators to treat-to-target in axial spondyloarthritis in clinical practice: a mixed methods study.
Rheumatol Int. 2025 Jan 31;45(2):41. doi: 10.1007/s00296-025-05795-6.
3
Barriers to, Facilitators of, and Interventions to Support Treat-to-Target Implementation in Rheumatoid Arthritis: A Systematic Review.
Arthritis Care Res (Hoboken). 2024 Dec;76(12):1626-1636. doi: 10.1002/acr.25408. Epub 2024 Sep 4.
4
Distinct oral DNA viral signatures in rheumatoid arthritis: a Pilot study.
J Oral Microbiol. 2024 May 1;16(1):2348260. doi: 10.1080/20002297.2024.2348260. eCollection 2024.
5
Effectiveness of a treat-to-target strategy in patients with moderate to severely active rheumatoid arthritis treated with abatacept.
Arthritis Res Ther. 2023 Sep 28;25(1):183. doi: 10.1186/s13075-023-03151-2.
6
Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe.
RMD Open. 2022 Dec;8(2). doi: 10.1136/rmdopen-2022-002658.
7
Critical appraisal of serum urate targets in the management of gout.
Nat Rev Rheumatol. 2022 Oct;18(10):603-609. doi: 10.1038/s41584-022-00816-1. Epub 2022 Aug 16.
8
Rheumatologist and Patient Mental Models for Treatment of Rheumatoid Arthritis Help Explain Low Treat-to-Target Rates.
ACR Open Rheumatol. 2022 Aug;4(8):700-710. doi: 10.1002/acr2.11443. Epub 2022 Jun 6.
9
Disease-modifying antirheumatic drug prescription patterns in adult rheumatoid arthritis patients in routine clinical practice in Spain.
Eur J Rheumatol. 2020 Sep 3;7(4):149-57. doi: 10.5152/eurjrheum.2020.19053.
10
New Rheumatoid Arthritis Treatments for 'Old' Patients: Results of a Systematic Review.
Adv Ther. 2020 Sep;37(9):3676-3691. doi: 10.1007/s12325-020-01435-6. Epub 2020 Jul 23.
本文引用的文献
1
Mobile Apps for Individuals With Rheumatoid Arthritis: A Systematic Review.
J Clin Rheumatol. 2019 Apr;25(3):133-141. doi: 10.1097/RHU.0000000000000800.
2
Treat to target, remission and low disease activity in SLE.
Best Pract Res Clin Rheumatol. 2017 Jun;31(3):342-350. doi: 10.1016/j.berh.2017.09.009. Epub 2017 Oct 13.
3
Standardizing and personalizing the treat to target (T2T) approach for rheumatoid arthritis using the Patient-Reported Outcomes Measurement Information System (PROMIS): baseline findings on patient-centered treatment priorities.
Clin Rheumatol. 2017 Aug;36(8):1729-1736. doi: 10.1007/s10067-017-3731-5. Epub 2017 Jun 26.
4
Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study.
Ann Rheum Dis. 2017 Oct;76(10):1693-1699. doi: 10.1136/annrheumdis-2016-210997. Epub 2017 Jun 12.
5
Rheumatoid Arthritis Patients' Motivations for Accepting or Resisting Disease-Modifying Antirheumatic Drug Treatment Regimens.
Arthritis Care Res (Hoboken). 2018 Apr;70(4):533-541. doi: 10.1002/acr.23301. Epub 2018 Mar 11.
6
Implementation of Treat-to-Target in Rheumatoid Arthritis Through a Learning Collaborative: Results of a Randomized Controlled Trial.
Arthritis Rheumatol. 2017 Jul;69(7):1374-1380. doi: 10.1002/art.40111. Epub 2017 May 31.
7
Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians.
Ann Intern Med. 2017 Jan 3;166(1):58-68. doi: 10.7326/M16-0570. Epub 2016 Nov 1.
8
Treat-to-target (T2T) recommendations for gout.
Ann Rheum Dis. 2017 Apr;76(4):632-638. doi: 10.1136/annrheumdis-2016-209467. Epub 2016 Sep 22.
9
2016 updated EULAR evidence-based recommendations for the management of gout.
Ann Rheum Dis. 2017 Jan;76(1):29-42. doi: 10.1136/annrheumdis-2016-209707. Epub 2016 Jul 25.
10
Patient-Reported Outcomes in Rheumatoid Arthritis.
Rheum Dis Clin North Am. 2016 May;42(2):219-37. doi: 10.1016/j.rdc.2016.01.010. Epub 2016 Mar 17.
Zotero 插件